Pregnancy is a delicate phase where drug safety becomes critical. Certain medications can cause teratogenic malformations—structural or functional defects in the developing fetus—especially during the first trimester when organogenesis is underway.
This article explains types of teratogenic drugs, their safety classification, WHO guidelines, and in-depth information on warfarin use in pregnancy.
Table of Contents
1. What Are Teratogenic Drugs?
Teratogenic drugs are medications that disturb fetal development, leading to birth defects, growth restriction, or neurodevelopmental issues. The effects depend on:
- Type of drug
- Dosage
- Timing of exposure
- Maternal-fetal health status
2. Why the First Trimester Is High-Risk
- Weeks 1–12: Organ formation occurs, so even small exposures can lead to permanent structural malformations.
- Weeks 13–28: Functional defects, growth issues, and CNS abnormalities can develop.
- Weeks 29–40: Drugs may cause preterm labor, ductus arteriosus closure, or bleeding disorders.
3. WHO Drug Safety Categories
The World Health Organization and clinical pharmacology references like Katzung and K.D. Tripathi group drugs by fetal safety:
| Category | Meaning |
| A | Safe (human studies confirm) |
| B | No proven risk in humans |
| C | Risk cannot be ruled out; use only if benefits outweigh risks |
| D | Positive evidence of fetal risk; use in life-threatening conditions only |
| X | Contraindicated—risks outweigh any potential benefits |
4. Highly Teratogenic Drugs (Avoid in Pregnancy)
These drugs have strong evidence of fetal harm and are Category X or high D:
- Isotretinoin, Acitretin → Craniofacial, cardiac, CNS defects
- Thalidomide → Phocomelia (limb shortening), organ malformations
- Valproic Acid → Neural tube defects, heart and limb malformations
- Methotrexate → Cranial dysostosis, limb abnormalities, growth restriction
- Warfarin → Fetal warfarin syndrome, CNS damage, miscarriage
- Mycophenolate → Ear malformations, cleft lip/palate
- High-dose Vitamin A → Severe CNS and facial defects
5. Moderate to Low Risk Drugs (Use With Caution)
- Lithium → Rare heart defect (Ebstein anomaly)
- Azole Antifungals → Craniofacial defects in high doses (>400 mg/day)
- ACE Inhibitors → Fetal renal failure, oligohydramnios in later trimesters
- Atenolol / Beta-Blockers → Fetal growth restriction
- NSAIDs (late pregnancy) → Premature ductus arteriosus closure
6. WHO & Clinical Guidelines on Warfarin
Warfarin is generally contraindicated in pregnancy due to high teratogenicity:
Risks
- First trimester: 5–30% risk of fetal warfarin syndrome
- Any trimester: CNS damage, fetal bleeding, miscarriage, stillbirth
Fetal Warfarin Syndrome Features:
- Nasal hypoplasia
- Stippled epiphyses (bone deformities)
- Intellectual disability
- Growth restriction
WHO & Expert Recommendations
- First-line anticoagulant in pregnancy: Low Molecular Weight Heparin (LMWH)
- Unfractionated Heparin (UFH): Alternative when rapid reversal is needed
- Warfarin use: Only considered in special cases (e.g., high-risk mechanical heart valves)
- LMWH in 1st trimester
Carefully monitored warfarin in mid-pregnancy if benefits outweigh risk
- Switch back to heparin before delivery to prevent fetal bleeding
- LMWH in 1st trimester
7. Safer Drug Alternatives
| Indication | Safer Option | Notes |
| Anticoagulation | LMWH / UFH | No placental transfer |
| Hypertension | Labetalol, Methyldopa | Well-studied in pregnancy |
| Epilepsy | Lamotrigine | Lowest teratogenic risk among antiepileptics |
| Infection | Penicillin, Cephalosporins | Category B drugs |
8. Drug Safety Classification Table
| Safety Tier | Examples | Recommendation |
| Highly Teratogenic | Isotretinoin, Thalidomide, Warfarin, Methotrexate, Valproate | Avoid completely |
| Moderate Risk | Lithium, ACE inhibitors, Atenolol, NSAIDs | Use only if no alternatives |
| Safer | LMWH, Penicillin, Methyldopa | Preferred during pregnancy |
9. Safety Precautions for Prescribing in Pregnancy
- Always confirm pregnancy status before prescribing
- Avoid prescribing in the first trimester unless life-saving
- Use the lowest effective dose for the shortest time
- Prefer drugs with a long history of safe use in pregnancy
- Engage in multidisciplinary care with obstetricians, cardiologists, and clinical pharmacologists
Final Takeaway
The choice of drugs during pregnancy should always be evidence-based, risk-benefit balanced, and aligned with WHO recommendations.
For warfarin, its use should be exceptional, with most cases managed using LMWH or UFH to protect both mother and fetus.
For more updates, follow us on X (Twitter), Instagram & Facebook. And our website MED COLLEGE DARSHAN.
